FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal...

18
Cell & Gene Therapy Manufacturing Capacities in Europe 2017 COBRA BIOLOGICS Overall Capacity: 2000+m² Spare capacity: 2017: 60% | 2018: 80% OXFORD BIOMEDICA Overall Capacity: 1200m² Spare capacity: Enquire ROSLIN CELLS Overall Capacity: 150m² Spare capacity: 2017: 30% | 2018: 60% CELL & GENE THERAPY CATAPULT Spare capacity: Facility to open mid 2017 FINVECTOR Overall Capacity: 600m² Spare capacity: 2017: Available | 2018: Available YPOSKESI Overall Capacity: 2000m² Spare capacity: Enquire CELL FOR CURE Overall Capacity: 3600m² + Spare capacity: Confidential NOVASEP Overall Capacity: 900m² Spare capacity: Enquire BATAVIA BIOSCIENCES Overall Capacity: 250m² Spare capacity: Enquire LONZA Overall Capacity: 1500m² Spare capacity: Expanding according to client needs ATVIO Overall Capacity: 100m² Spare capacity: 2017: 66% 2018: 33% 2019: 20% MOLMED Overall Capacity: 2100m² Spare capacity: Enquire EUFETS Spare capacity: 2017: 30% | 2018: 70% FRAUNHOFER IZI Spare capacity: 2017: 3 | 2018: 2 APCETH Overall Capacity: 600m², thereof 130m² class B Spare capacity: 2017 / 2018: available EUROGENTEC Overall Capacity: 600m² Spare capacity: Enquire MASTHERCELL Overall Capacity: 600m² + 600m² Spare capacity: Enquire

Transcript of FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal...

Page 1: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Cell amp Gene Therapy

Manufacturing Capacities

in Europe

2017

COBRA BIOLOGICS

Overall Capacity 2000+msup2

Spare capacity 2017 60 | 2018 80

OXFORD BIOMEDICA

Overall Capacity 1200msup2

Spare capacity Enquire

ROSLIN CELLS

Overall Capacity 150msup2

Spare capacity 2017 30 | 2018 60

CELL amp GENE THERAPY CATAPULT

Spare capacity Facility to open mid 2017

FINVECTOR

Overall Capacity 600msup2

Spare capacity 2017 Available | 2018 Available

YPOSKESI

Overall Capacity 2000msup2

Spare capacity Enquire

CELL FOR CURE

Overall Capacity 3600msup2 +

Spare capacity Confidential

NOVASEP

Overall Capacity 900msup2

Spare capacity Enquire

BATAVIA BIOSCIENCES

Overall Capacity 250msup2

Spare capacity Enquire

LONZA

Overall Capacity 1500msup2

Spare capacity Expanding according to client needs

ATVIO

Overall Capacity 100msup2

Spare capacity 2017 66 2018 33 2019 20

MOLMED

Overall Capacity 2100msup2

Spare capacity Enquire

EUFETS

Spare capacity 2017 30 | 2018 70

FRAUNHOFER IZI

Spare capacity 2017 3 | 2018 2

APCETH

Overall Capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 2018 available

EUROGENTEC

Overall Capacity 600msup2

Spare capacity Enquire

MASTHERCELL

Overall Capacity 600msup2 + 600msup2

Spare capacity Enquire

Product types DNA

Virus

Mammalian Protein

Microbiota

Stand Alone

Customer focused technologies

Clean rooms 17 suites (including 2x mammalian)

Overall capacity 2000+ msup2 (across three GMP facilities)

Spare capacity 2017 60 | 2018 80

Virus DNA amp Small Scale Microbial

Production Facility

Cobra Biologics

Stephenson Building

The Science Park

Keele ST5 5SP UK

+44 1782 714 181

Philip Ridley-Smith Sales amp Marketing Director

philipridley-smithcobrabiocom

+44 (0)208 246 5895 (London UK)

Sharon Brownlow Business Development Manager

sharonbrownlowcobrabiocom

+44 (0)7974 424754 (Leeds UK)

wwwcobrabiocom

Contact Us About Us

To map gt

Product types Lentivirus

AAV

Adenovirus

HEK293

HEK293T

A459

SF9

Clean rooms 3 cGMP suites

Overall capacity 600msup2

Spare capacity 2017 Available | 2018 Available

Finvector Vision Therapies

Microkatu 1S FI70210

Kuopio

Finland

Kassim Kolia Head of Laboratory

infofinvectorcom

0151 268 7200

wwwfinvectorcom

Contact Us About Us

To map gt

Product types Human pluripotent stem cells

hPSC-derived cells

Multipotent cells

Clean rooms - Suite 1 1 Grade B processing room

+ 2 Grade A MSCs 1 Shared Grade C support room

- Suite 2 1 Grade B processing room

+ 2 Grade A MSCs 1 Shared Grade C support room

- Suite 3 1 Grade C processing room with CliniMACs

Overall capacity 150msup2

Spare capacity 2017 30 | 2018 60

Cellular Therapy Facility

Scottish Centre for Regenerative Medicine

5 Little France Drive

Edinburgh BioQuarter

Edinburgh

EH16 4UU

Janet Downie Chief Executive Officer

janetdownieroslincellscom

0131 658 5182

wwwroslincellscomroslincelltherapies

Contact Us About Us

To map gt

Product types retroviral lentiviral vectors and gene manipulated cells

medicinal products include various types of human

stemcells including hematopoietic stem cells T-cells

and other progenitor cells

Clean rooms gt30 B-grade and C-grade suites for

vector manufacturing and cell manipulation

Overall capacity 2100msup2

Spare capacity Enquire lucaalbericimolmedcom

MOLMED

via Olgettina 58

Milano

Italy

Luca Alberici Business Development Director

lucaalbericimolmedcom

wwwmolmedcom

Contact Us About Us

To map gt

Manufacturing standardization amp large-scale manufacturing challenges

Interview James Brown at Aldevron

Product types Lentiviral vectors from human cell lines

both in adherent and serum free suspension modes

Clean rooms The total operational clean room area is 1200msup2

in upstream and downstream processing areas

across multiple independent suites and sites

- GMP1 (HArrow House) 390msup2

- GMP (Harrow House suspension culture facility) 250msup2

- GMP4 (Yarnton) 560msup2

Overall capacity 1200msup2

Spare capacity please enquire for more information

Oxford BioMedica (UK)

Limited Windrush Court

Transport Way

Oxford

OX4 6LT

Peter Nolan

enquiriesoxfordbiomedicacouk

+44 (0) 1865 785300

wwwoxfordbiomedicacouk

Contact Us About Us

To map gt

Product types Non-manipulated

manipulated

gene-modified allogeneic a

autologous cell therapies

Clean rooms High number of B-rooms from smaller scale

phase I processes to large scale B-rooms for

Phase IIIcommercial ATMPs

Overall capacity 1500msup2

Spare capacity Expanding according to client needs

Lonza

Oxfordlaan 70

6229 EV Maastricht

The Netherlands

Soenke Brunswieck Director Business Deveolpment amp Project Management

Sbrunswieckpharmacelnl

wwwlonzanl

Contact Us About Us

To map gt

Product types Retroviral vectors (also SIN configuration)

RNA (as drug product or ldquostarting materialrdquo

for cell therapy)

Cell banks

Cell therapeutic products

(stem cells T cells DCs Cell lines)

Clean rooms 7 clean rooms class B

4 clean rooms class C

Spare capacity 2017 30 | 2018 70

EUFETS GmbH

Vollmersbachstr 66

55743 Idar-Oberstein

Germany

Simone Gans

infoeufetscom

wwweufetscom

Contact Us About Us

To map gt

Product types Advanced Therapy Medicinal Products (ATMPs)

like gene therapies (eg CAR-T cells)

somatic cell therapies (eg dendritic cells)

tissue engineering products

hematopoietic stem cells

Clean rooms - 10 completely separated clean room

- Total 21 class B manufacturing rooms

Spare capacity 2017 3 clean room suites with two class B

manufacturing rooms each

2018 2 clean room suites with two

class B manufacturing rooms each

Fraunhofer Institute for Cell Therapy

and Immunology IZI

Perlickstrasse 1

D-04103 Leipzig

Germany

Dr Gerno Schmiedeknecht

Gernoschmiedeknechtizifraunhoferde

wwwizifraunhoferde

Contact Us About Us

To map gt

Product types Lentivirus

Associated adenovirus (AAVs)

CD34+ transduced cells

Embryonic stem cells

iPS cells

Clean rooms 4 suites for Drug substance manufacturing

2 suites for FampF

Overall capacity Approx 2000msup2

Spare capacity Enquire contactyposkesicom

YPOSKESI

26 rue Henri Auguste-Desbruegraveres

F-91100 CORBEIL-ESSONNES

France

Alain LAMPROYE

contactyposkesicom

wwwyposkesicom

Contact Us About Us

To map gt

Discussing the future of bioprocessing

with Saint Gobain Akron

Remedi and CRC for Cell Therapy

Manufacturing

Product types Retroviral vectors (ie Lentiviral)

Adeno-associated viral vectors (AAV)

Measles vectors

Adenoviral vectors and Pox virus vectors (MVA)

Ample experience with cell lines like HEK293 VERO CHO

MCDK and customer specific platforms

Clean rooms 5

Overall capacity Approx 250msup2

Spare capacity Enquire infobataviabiosciences

Batavia Biosciences

Zernikedraaf 16

2333 CN Leiden

The Netherlands

V Franssen

infobataviabiosciences

wwwbataviabiosciencescom

Contact Us About Us

To map gt

The Rapporteurrsquos Report explores the role of automation in bioprocessing

Product types Genetically modified and native ATMPs

mesenchymal stem cells (MSC)

hematopoietic stem cells (HSC)

lymphocytes amp monocytes (eg NK DC)

retro- and lentiviral vector transduction

Clean rooms 7 (5 class B 2 class C)

Overall capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 available

2018 available

APCETH

GmbH amp Co KG

Haidgraben 5

85521 Ottobrunn

Germany

Christine Guumlnther CEO

Ulrike Verzetnitsch CTO

contactapcethcom

+49 (0)89 7009608 0

wwwapcethcom

Contact Us About Us

To map gt

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 2: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types DNA

Virus

Mammalian Protein

Microbiota

Stand Alone

Customer focused technologies

Clean rooms 17 suites (including 2x mammalian)

Overall capacity 2000+ msup2 (across three GMP facilities)

Spare capacity 2017 60 | 2018 80

Virus DNA amp Small Scale Microbial

Production Facility

Cobra Biologics

Stephenson Building

The Science Park

Keele ST5 5SP UK

+44 1782 714 181

Philip Ridley-Smith Sales amp Marketing Director

philipridley-smithcobrabiocom

+44 (0)208 246 5895 (London UK)

Sharon Brownlow Business Development Manager

sharonbrownlowcobrabiocom

+44 (0)7974 424754 (Leeds UK)

wwwcobrabiocom

Contact Us About Us

To map gt

Product types Lentivirus

AAV

Adenovirus

HEK293

HEK293T

A459

SF9

Clean rooms 3 cGMP suites

Overall capacity 600msup2

Spare capacity 2017 Available | 2018 Available

Finvector Vision Therapies

Microkatu 1S FI70210

Kuopio

Finland

Kassim Kolia Head of Laboratory

infofinvectorcom

0151 268 7200

wwwfinvectorcom

Contact Us About Us

To map gt

Product types Human pluripotent stem cells

hPSC-derived cells

Multipotent cells

Clean rooms - Suite 1 1 Grade B processing room

+ 2 Grade A MSCs 1 Shared Grade C support room

- Suite 2 1 Grade B processing room

+ 2 Grade A MSCs 1 Shared Grade C support room

- Suite 3 1 Grade C processing room with CliniMACs

Overall capacity 150msup2

Spare capacity 2017 30 | 2018 60

Cellular Therapy Facility

Scottish Centre for Regenerative Medicine

5 Little France Drive

Edinburgh BioQuarter

Edinburgh

EH16 4UU

Janet Downie Chief Executive Officer

janetdownieroslincellscom

0131 658 5182

wwwroslincellscomroslincelltherapies

Contact Us About Us

To map gt

Product types retroviral lentiviral vectors and gene manipulated cells

medicinal products include various types of human

stemcells including hematopoietic stem cells T-cells

and other progenitor cells

Clean rooms gt30 B-grade and C-grade suites for

vector manufacturing and cell manipulation

Overall capacity 2100msup2

Spare capacity Enquire lucaalbericimolmedcom

MOLMED

via Olgettina 58

Milano

Italy

Luca Alberici Business Development Director

lucaalbericimolmedcom

wwwmolmedcom

Contact Us About Us

To map gt

Manufacturing standardization amp large-scale manufacturing challenges

Interview James Brown at Aldevron

Product types Lentiviral vectors from human cell lines

both in adherent and serum free suspension modes

Clean rooms The total operational clean room area is 1200msup2

in upstream and downstream processing areas

across multiple independent suites and sites

- GMP1 (HArrow House) 390msup2

- GMP (Harrow House suspension culture facility) 250msup2

- GMP4 (Yarnton) 560msup2

Overall capacity 1200msup2

Spare capacity please enquire for more information

Oxford BioMedica (UK)

Limited Windrush Court

Transport Way

Oxford

OX4 6LT

Peter Nolan

enquiriesoxfordbiomedicacouk

+44 (0) 1865 785300

wwwoxfordbiomedicacouk

Contact Us About Us

To map gt

Product types Non-manipulated

manipulated

gene-modified allogeneic a

autologous cell therapies

Clean rooms High number of B-rooms from smaller scale

phase I processes to large scale B-rooms for

Phase IIIcommercial ATMPs

Overall capacity 1500msup2

Spare capacity Expanding according to client needs

Lonza

Oxfordlaan 70

6229 EV Maastricht

The Netherlands

Soenke Brunswieck Director Business Deveolpment amp Project Management

Sbrunswieckpharmacelnl

wwwlonzanl

Contact Us About Us

To map gt

Product types Retroviral vectors (also SIN configuration)

RNA (as drug product or ldquostarting materialrdquo

for cell therapy)

Cell banks

Cell therapeutic products

(stem cells T cells DCs Cell lines)

Clean rooms 7 clean rooms class B

4 clean rooms class C

Spare capacity 2017 30 | 2018 70

EUFETS GmbH

Vollmersbachstr 66

55743 Idar-Oberstein

Germany

Simone Gans

infoeufetscom

wwweufetscom

Contact Us About Us

To map gt

Product types Advanced Therapy Medicinal Products (ATMPs)

like gene therapies (eg CAR-T cells)

somatic cell therapies (eg dendritic cells)

tissue engineering products

hematopoietic stem cells

Clean rooms - 10 completely separated clean room

- Total 21 class B manufacturing rooms

Spare capacity 2017 3 clean room suites with two class B

manufacturing rooms each

2018 2 clean room suites with two

class B manufacturing rooms each

Fraunhofer Institute for Cell Therapy

and Immunology IZI

Perlickstrasse 1

D-04103 Leipzig

Germany

Dr Gerno Schmiedeknecht

Gernoschmiedeknechtizifraunhoferde

wwwizifraunhoferde

Contact Us About Us

To map gt

Product types Lentivirus

Associated adenovirus (AAVs)

CD34+ transduced cells

Embryonic stem cells

iPS cells

Clean rooms 4 suites for Drug substance manufacturing

2 suites for FampF

Overall capacity Approx 2000msup2

Spare capacity Enquire contactyposkesicom

YPOSKESI

26 rue Henri Auguste-Desbruegraveres

F-91100 CORBEIL-ESSONNES

France

Alain LAMPROYE

contactyposkesicom

wwwyposkesicom

Contact Us About Us

To map gt

Discussing the future of bioprocessing

with Saint Gobain Akron

Remedi and CRC for Cell Therapy

Manufacturing

Product types Retroviral vectors (ie Lentiviral)

Adeno-associated viral vectors (AAV)

Measles vectors

Adenoviral vectors and Pox virus vectors (MVA)

Ample experience with cell lines like HEK293 VERO CHO

MCDK and customer specific platforms

Clean rooms 5

Overall capacity Approx 250msup2

Spare capacity Enquire infobataviabiosciences

Batavia Biosciences

Zernikedraaf 16

2333 CN Leiden

The Netherlands

V Franssen

infobataviabiosciences

wwwbataviabiosciencescom

Contact Us About Us

To map gt

The Rapporteurrsquos Report explores the role of automation in bioprocessing

Product types Genetically modified and native ATMPs

mesenchymal stem cells (MSC)

hematopoietic stem cells (HSC)

lymphocytes amp monocytes (eg NK DC)

retro- and lentiviral vector transduction

Clean rooms 7 (5 class B 2 class C)

Overall capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 available

2018 available

APCETH

GmbH amp Co KG

Haidgraben 5

85521 Ottobrunn

Germany

Christine Guumlnther CEO

Ulrike Verzetnitsch CTO

contactapcethcom

+49 (0)89 7009608 0

wwwapcethcom

Contact Us About Us

To map gt

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 3: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Lentivirus

AAV

Adenovirus

HEK293

HEK293T

A459

SF9

Clean rooms 3 cGMP suites

Overall capacity 600msup2

Spare capacity 2017 Available | 2018 Available

Finvector Vision Therapies

Microkatu 1S FI70210

Kuopio

Finland

Kassim Kolia Head of Laboratory

infofinvectorcom

0151 268 7200

wwwfinvectorcom

Contact Us About Us

To map gt

Product types Human pluripotent stem cells

hPSC-derived cells

Multipotent cells

Clean rooms - Suite 1 1 Grade B processing room

+ 2 Grade A MSCs 1 Shared Grade C support room

- Suite 2 1 Grade B processing room

+ 2 Grade A MSCs 1 Shared Grade C support room

- Suite 3 1 Grade C processing room with CliniMACs

Overall capacity 150msup2

Spare capacity 2017 30 | 2018 60

Cellular Therapy Facility

Scottish Centre for Regenerative Medicine

5 Little France Drive

Edinburgh BioQuarter

Edinburgh

EH16 4UU

Janet Downie Chief Executive Officer

janetdownieroslincellscom

0131 658 5182

wwwroslincellscomroslincelltherapies

Contact Us About Us

To map gt

Product types retroviral lentiviral vectors and gene manipulated cells

medicinal products include various types of human

stemcells including hematopoietic stem cells T-cells

and other progenitor cells

Clean rooms gt30 B-grade and C-grade suites for

vector manufacturing and cell manipulation

Overall capacity 2100msup2

Spare capacity Enquire lucaalbericimolmedcom

MOLMED

via Olgettina 58

Milano

Italy

Luca Alberici Business Development Director

lucaalbericimolmedcom

wwwmolmedcom

Contact Us About Us

To map gt

Manufacturing standardization amp large-scale manufacturing challenges

Interview James Brown at Aldevron

Product types Lentiviral vectors from human cell lines

both in adherent and serum free suspension modes

Clean rooms The total operational clean room area is 1200msup2

in upstream and downstream processing areas

across multiple independent suites and sites

- GMP1 (HArrow House) 390msup2

- GMP (Harrow House suspension culture facility) 250msup2

- GMP4 (Yarnton) 560msup2

Overall capacity 1200msup2

Spare capacity please enquire for more information

Oxford BioMedica (UK)

Limited Windrush Court

Transport Way

Oxford

OX4 6LT

Peter Nolan

enquiriesoxfordbiomedicacouk

+44 (0) 1865 785300

wwwoxfordbiomedicacouk

Contact Us About Us

To map gt

Product types Non-manipulated

manipulated

gene-modified allogeneic a

autologous cell therapies

Clean rooms High number of B-rooms from smaller scale

phase I processes to large scale B-rooms for

Phase IIIcommercial ATMPs

Overall capacity 1500msup2

Spare capacity Expanding according to client needs

Lonza

Oxfordlaan 70

6229 EV Maastricht

The Netherlands

Soenke Brunswieck Director Business Deveolpment amp Project Management

Sbrunswieckpharmacelnl

wwwlonzanl

Contact Us About Us

To map gt

Product types Retroviral vectors (also SIN configuration)

RNA (as drug product or ldquostarting materialrdquo

for cell therapy)

Cell banks

Cell therapeutic products

(stem cells T cells DCs Cell lines)

Clean rooms 7 clean rooms class B

4 clean rooms class C

Spare capacity 2017 30 | 2018 70

EUFETS GmbH

Vollmersbachstr 66

55743 Idar-Oberstein

Germany

Simone Gans

infoeufetscom

wwweufetscom

Contact Us About Us

To map gt

Product types Advanced Therapy Medicinal Products (ATMPs)

like gene therapies (eg CAR-T cells)

somatic cell therapies (eg dendritic cells)

tissue engineering products

hematopoietic stem cells

Clean rooms - 10 completely separated clean room

- Total 21 class B manufacturing rooms

Spare capacity 2017 3 clean room suites with two class B

manufacturing rooms each

2018 2 clean room suites with two

class B manufacturing rooms each

Fraunhofer Institute for Cell Therapy

and Immunology IZI

Perlickstrasse 1

D-04103 Leipzig

Germany

Dr Gerno Schmiedeknecht

Gernoschmiedeknechtizifraunhoferde

wwwizifraunhoferde

Contact Us About Us

To map gt

Product types Lentivirus

Associated adenovirus (AAVs)

CD34+ transduced cells

Embryonic stem cells

iPS cells

Clean rooms 4 suites for Drug substance manufacturing

2 suites for FampF

Overall capacity Approx 2000msup2

Spare capacity Enquire contactyposkesicom

YPOSKESI

26 rue Henri Auguste-Desbruegraveres

F-91100 CORBEIL-ESSONNES

France

Alain LAMPROYE

contactyposkesicom

wwwyposkesicom

Contact Us About Us

To map gt

Discussing the future of bioprocessing

with Saint Gobain Akron

Remedi and CRC for Cell Therapy

Manufacturing

Product types Retroviral vectors (ie Lentiviral)

Adeno-associated viral vectors (AAV)

Measles vectors

Adenoviral vectors and Pox virus vectors (MVA)

Ample experience with cell lines like HEK293 VERO CHO

MCDK and customer specific platforms

Clean rooms 5

Overall capacity Approx 250msup2

Spare capacity Enquire infobataviabiosciences

Batavia Biosciences

Zernikedraaf 16

2333 CN Leiden

The Netherlands

V Franssen

infobataviabiosciences

wwwbataviabiosciencescom

Contact Us About Us

To map gt

The Rapporteurrsquos Report explores the role of automation in bioprocessing

Product types Genetically modified and native ATMPs

mesenchymal stem cells (MSC)

hematopoietic stem cells (HSC)

lymphocytes amp monocytes (eg NK DC)

retro- and lentiviral vector transduction

Clean rooms 7 (5 class B 2 class C)

Overall capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 available

2018 available

APCETH

GmbH amp Co KG

Haidgraben 5

85521 Ottobrunn

Germany

Christine Guumlnther CEO

Ulrike Verzetnitsch CTO

contactapcethcom

+49 (0)89 7009608 0

wwwapcethcom

Contact Us About Us

To map gt

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 4: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Human pluripotent stem cells

hPSC-derived cells

Multipotent cells

Clean rooms - Suite 1 1 Grade B processing room

+ 2 Grade A MSCs 1 Shared Grade C support room

- Suite 2 1 Grade B processing room

+ 2 Grade A MSCs 1 Shared Grade C support room

- Suite 3 1 Grade C processing room with CliniMACs

Overall capacity 150msup2

Spare capacity 2017 30 | 2018 60

Cellular Therapy Facility

Scottish Centre for Regenerative Medicine

5 Little France Drive

Edinburgh BioQuarter

Edinburgh

EH16 4UU

Janet Downie Chief Executive Officer

janetdownieroslincellscom

0131 658 5182

wwwroslincellscomroslincelltherapies

Contact Us About Us

To map gt

Product types retroviral lentiviral vectors and gene manipulated cells

medicinal products include various types of human

stemcells including hematopoietic stem cells T-cells

and other progenitor cells

Clean rooms gt30 B-grade and C-grade suites for

vector manufacturing and cell manipulation

Overall capacity 2100msup2

Spare capacity Enquire lucaalbericimolmedcom

MOLMED

via Olgettina 58

Milano

Italy

Luca Alberici Business Development Director

lucaalbericimolmedcom

wwwmolmedcom

Contact Us About Us

To map gt

Manufacturing standardization amp large-scale manufacturing challenges

Interview James Brown at Aldevron

Product types Lentiviral vectors from human cell lines

both in adherent and serum free suspension modes

Clean rooms The total operational clean room area is 1200msup2

in upstream and downstream processing areas

across multiple independent suites and sites

- GMP1 (HArrow House) 390msup2

- GMP (Harrow House suspension culture facility) 250msup2

- GMP4 (Yarnton) 560msup2

Overall capacity 1200msup2

Spare capacity please enquire for more information

Oxford BioMedica (UK)

Limited Windrush Court

Transport Way

Oxford

OX4 6LT

Peter Nolan

enquiriesoxfordbiomedicacouk

+44 (0) 1865 785300

wwwoxfordbiomedicacouk

Contact Us About Us

To map gt

Product types Non-manipulated

manipulated

gene-modified allogeneic a

autologous cell therapies

Clean rooms High number of B-rooms from smaller scale

phase I processes to large scale B-rooms for

Phase IIIcommercial ATMPs

Overall capacity 1500msup2

Spare capacity Expanding according to client needs

Lonza

Oxfordlaan 70

6229 EV Maastricht

The Netherlands

Soenke Brunswieck Director Business Deveolpment amp Project Management

Sbrunswieckpharmacelnl

wwwlonzanl

Contact Us About Us

To map gt

Product types Retroviral vectors (also SIN configuration)

RNA (as drug product or ldquostarting materialrdquo

for cell therapy)

Cell banks

Cell therapeutic products

(stem cells T cells DCs Cell lines)

Clean rooms 7 clean rooms class B

4 clean rooms class C

Spare capacity 2017 30 | 2018 70

EUFETS GmbH

Vollmersbachstr 66

55743 Idar-Oberstein

Germany

Simone Gans

infoeufetscom

wwweufetscom

Contact Us About Us

To map gt

Product types Advanced Therapy Medicinal Products (ATMPs)

like gene therapies (eg CAR-T cells)

somatic cell therapies (eg dendritic cells)

tissue engineering products

hematopoietic stem cells

Clean rooms - 10 completely separated clean room

- Total 21 class B manufacturing rooms

Spare capacity 2017 3 clean room suites with two class B

manufacturing rooms each

2018 2 clean room suites with two

class B manufacturing rooms each

Fraunhofer Institute for Cell Therapy

and Immunology IZI

Perlickstrasse 1

D-04103 Leipzig

Germany

Dr Gerno Schmiedeknecht

Gernoschmiedeknechtizifraunhoferde

wwwizifraunhoferde

Contact Us About Us

To map gt

Product types Lentivirus

Associated adenovirus (AAVs)

CD34+ transduced cells

Embryonic stem cells

iPS cells

Clean rooms 4 suites for Drug substance manufacturing

2 suites for FampF

Overall capacity Approx 2000msup2

Spare capacity Enquire contactyposkesicom

YPOSKESI

26 rue Henri Auguste-Desbruegraveres

F-91100 CORBEIL-ESSONNES

France

Alain LAMPROYE

contactyposkesicom

wwwyposkesicom

Contact Us About Us

To map gt

Discussing the future of bioprocessing

with Saint Gobain Akron

Remedi and CRC for Cell Therapy

Manufacturing

Product types Retroviral vectors (ie Lentiviral)

Adeno-associated viral vectors (AAV)

Measles vectors

Adenoviral vectors and Pox virus vectors (MVA)

Ample experience with cell lines like HEK293 VERO CHO

MCDK and customer specific platforms

Clean rooms 5

Overall capacity Approx 250msup2

Spare capacity Enquire infobataviabiosciences

Batavia Biosciences

Zernikedraaf 16

2333 CN Leiden

The Netherlands

V Franssen

infobataviabiosciences

wwwbataviabiosciencescom

Contact Us About Us

To map gt

The Rapporteurrsquos Report explores the role of automation in bioprocessing

Product types Genetically modified and native ATMPs

mesenchymal stem cells (MSC)

hematopoietic stem cells (HSC)

lymphocytes amp monocytes (eg NK DC)

retro- and lentiviral vector transduction

Clean rooms 7 (5 class B 2 class C)

Overall capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 available

2018 available

APCETH

GmbH amp Co KG

Haidgraben 5

85521 Ottobrunn

Germany

Christine Guumlnther CEO

Ulrike Verzetnitsch CTO

contactapcethcom

+49 (0)89 7009608 0

wwwapcethcom

Contact Us About Us

To map gt

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 5: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types retroviral lentiviral vectors and gene manipulated cells

medicinal products include various types of human

stemcells including hematopoietic stem cells T-cells

and other progenitor cells

Clean rooms gt30 B-grade and C-grade suites for

vector manufacturing and cell manipulation

Overall capacity 2100msup2

Spare capacity Enquire lucaalbericimolmedcom

MOLMED

via Olgettina 58

Milano

Italy

Luca Alberici Business Development Director

lucaalbericimolmedcom

wwwmolmedcom

Contact Us About Us

To map gt

Manufacturing standardization amp large-scale manufacturing challenges

Interview James Brown at Aldevron

Product types Lentiviral vectors from human cell lines

both in adherent and serum free suspension modes

Clean rooms The total operational clean room area is 1200msup2

in upstream and downstream processing areas

across multiple independent suites and sites

- GMP1 (HArrow House) 390msup2

- GMP (Harrow House suspension culture facility) 250msup2

- GMP4 (Yarnton) 560msup2

Overall capacity 1200msup2

Spare capacity please enquire for more information

Oxford BioMedica (UK)

Limited Windrush Court

Transport Way

Oxford

OX4 6LT

Peter Nolan

enquiriesoxfordbiomedicacouk

+44 (0) 1865 785300

wwwoxfordbiomedicacouk

Contact Us About Us

To map gt

Product types Non-manipulated

manipulated

gene-modified allogeneic a

autologous cell therapies

Clean rooms High number of B-rooms from smaller scale

phase I processes to large scale B-rooms for

Phase IIIcommercial ATMPs

Overall capacity 1500msup2

Spare capacity Expanding according to client needs

Lonza

Oxfordlaan 70

6229 EV Maastricht

The Netherlands

Soenke Brunswieck Director Business Deveolpment amp Project Management

Sbrunswieckpharmacelnl

wwwlonzanl

Contact Us About Us

To map gt

Product types Retroviral vectors (also SIN configuration)

RNA (as drug product or ldquostarting materialrdquo

for cell therapy)

Cell banks

Cell therapeutic products

(stem cells T cells DCs Cell lines)

Clean rooms 7 clean rooms class B

4 clean rooms class C

Spare capacity 2017 30 | 2018 70

EUFETS GmbH

Vollmersbachstr 66

55743 Idar-Oberstein

Germany

Simone Gans

infoeufetscom

wwweufetscom

Contact Us About Us

To map gt

Product types Advanced Therapy Medicinal Products (ATMPs)

like gene therapies (eg CAR-T cells)

somatic cell therapies (eg dendritic cells)

tissue engineering products

hematopoietic stem cells

Clean rooms - 10 completely separated clean room

- Total 21 class B manufacturing rooms

Spare capacity 2017 3 clean room suites with two class B

manufacturing rooms each

2018 2 clean room suites with two

class B manufacturing rooms each

Fraunhofer Institute for Cell Therapy

and Immunology IZI

Perlickstrasse 1

D-04103 Leipzig

Germany

Dr Gerno Schmiedeknecht

Gernoschmiedeknechtizifraunhoferde

wwwizifraunhoferde

Contact Us About Us

To map gt

Product types Lentivirus

Associated adenovirus (AAVs)

CD34+ transduced cells

Embryonic stem cells

iPS cells

Clean rooms 4 suites for Drug substance manufacturing

2 suites for FampF

Overall capacity Approx 2000msup2

Spare capacity Enquire contactyposkesicom

YPOSKESI

26 rue Henri Auguste-Desbruegraveres

F-91100 CORBEIL-ESSONNES

France

Alain LAMPROYE

contactyposkesicom

wwwyposkesicom

Contact Us About Us

To map gt

Discussing the future of bioprocessing

with Saint Gobain Akron

Remedi and CRC for Cell Therapy

Manufacturing

Product types Retroviral vectors (ie Lentiviral)

Adeno-associated viral vectors (AAV)

Measles vectors

Adenoviral vectors and Pox virus vectors (MVA)

Ample experience with cell lines like HEK293 VERO CHO

MCDK and customer specific platforms

Clean rooms 5

Overall capacity Approx 250msup2

Spare capacity Enquire infobataviabiosciences

Batavia Biosciences

Zernikedraaf 16

2333 CN Leiden

The Netherlands

V Franssen

infobataviabiosciences

wwwbataviabiosciencescom

Contact Us About Us

To map gt

The Rapporteurrsquos Report explores the role of automation in bioprocessing

Product types Genetically modified and native ATMPs

mesenchymal stem cells (MSC)

hematopoietic stem cells (HSC)

lymphocytes amp monocytes (eg NK DC)

retro- and lentiviral vector transduction

Clean rooms 7 (5 class B 2 class C)

Overall capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 available

2018 available

APCETH

GmbH amp Co KG

Haidgraben 5

85521 Ottobrunn

Germany

Christine Guumlnther CEO

Ulrike Verzetnitsch CTO

contactapcethcom

+49 (0)89 7009608 0

wwwapcethcom

Contact Us About Us

To map gt

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 6: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Lentiviral vectors from human cell lines

both in adherent and serum free suspension modes

Clean rooms The total operational clean room area is 1200msup2

in upstream and downstream processing areas

across multiple independent suites and sites

- GMP1 (HArrow House) 390msup2

- GMP (Harrow House suspension culture facility) 250msup2

- GMP4 (Yarnton) 560msup2

Overall capacity 1200msup2

Spare capacity please enquire for more information

Oxford BioMedica (UK)

Limited Windrush Court

Transport Way

Oxford

OX4 6LT

Peter Nolan

enquiriesoxfordbiomedicacouk

+44 (0) 1865 785300

wwwoxfordbiomedicacouk

Contact Us About Us

To map gt

Product types Non-manipulated

manipulated

gene-modified allogeneic a

autologous cell therapies

Clean rooms High number of B-rooms from smaller scale

phase I processes to large scale B-rooms for

Phase IIIcommercial ATMPs

Overall capacity 1500msup2

Spare capacity Expanding according to client needs

Lonza

Oxfordlaan 70

6229 EV Maastricht

The Netherlands

Soenke Brunswieck Director Business Deveolpment amp Project Management

Sbrunswieckpharmacelnl

wwwlonzanl

Contact Us About Us

To map gt

Product types Retroviral vectors (also SIN configuration)

RNA (as drug product or ldquostarting materialrdquo

for cell therapy)

Cell banks

Cell therapeutic products

(stem cells T cells DCs Cell lines)

Clean rooms 7 clean rooms class B

4 clean rooms class C

Spare capacity 2017 30 | 2018 70

EUFETS GmbH

Vollmersbachstr 66

55743 Idar-Oberstein

Germany

Simone Gans

infoeufetscom

wwweufetscom

Contact Us About Us

To map gt

Product types Advanced Therapy Medicinal Products (ATMPs)

like gene therapies (eg CAR-T cells)

somatic cell therapies (eg dendritic cells)

tissue engineering products

hematopoietic stem cells

Clean rooms - 10 completely separated clean room

- Total 21 class B manufacturing rooms

Spare capacity 2017 3 clean room suites with two class B

manufacturing rooms each

2018 2 clean room suites with two

class B manufacturing rooms each

Fraunhofer Institute for Cell Therapy

and Immunology IZI

Perlickstrasse 1

D-04103 Leipzig

Germany

Dr Gerno Schmiedeknecht

Gernoschmiedeknechtizifraunhoferde

wwwizifraunhoferde

Contact Us About Us

To map gt

Product types Lentivirus

Associated adenovirus (AAVs)

CD34+ transduced cells

Embryonic stem cells

iPS cells

Clean rooms 4 suites for Drug substance manufacturing

2 suites for FampF

Overall capacity Approx 2000msup2

Spare capacity Enquire contactyposkesicom

YPOSKESI

26 rue Henri Auguste-Desbruegraveres

F-91100 CORBEIL-ESSONNES

France

Alain LAMPROYE

contactyposkesicom

wwwyposkesicom

Contact Us About Us

To map gt

Discussing the future of bioprocessing

with Saint Gobain Akron

Remedi and CRC for Cell Therapy

Manufacturing

Product types Retroviral vectors (ie Lentiviral)

Adeno-associated viral vectors (AAV)

Measles vectors

Adenoviral vectors and Pox virus vectors (MVA)

Ample experience with cell lines like HEK293 VERO CHO

MCDK and customer specific platforms

Clean rooms 5

Overall capacity Approx 250msup2

Spare capacity Enquire infobataviabiosciences

Batavia Biosciences

Zernikedraaf 16

2333 CN Leiden

The Netherlands

V Franssen

infobataviabiosciences

wwwbataviabiosciencescom

Contact Us About Us

To map gt

The Rapporteurrsquos Report explores the role of automation in bioprocessing

Product types Genetically modified and native ATMPs

mesenchymal stem cells (MSC)

hematopoietic stem cells (HSC)

lymphocytes amp monocytes (eg NK DC)

retro- and lentiviral vector transduction

Clean rooms 7 (5 class B 2 class C)

Overall capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 available

2018 available

APCETH

GmbH amp Co KG

Haidgraben 5

85521 Ottobrunn

Germany

Christine Guumlnther CEO

Ulrike Verzetnitsch CTO

contactapcethcom

+49 (0)89 7009608 0

wwwapcethcom

Contact Us About Us

To map gt

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 7: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Non-manipulated

manipulated

gene-modified allogeneic a

autologous cell therapies

Clean rooms High number of B-rooms from smaller scale

phase I processes to large scale B-rooms for

Phase IIIcommercial ATMPs

Overall capacity 1500msup2

Spare capacity Expanding according to client needs

Lonza

Oxfordlaan 70

6229 EV Maastricht

The Netherlands

Soenke Brunswieck Director Business Deveolpment amp Project Management

Sbrunswieckpharmacelnl

wwwlonzanl

Contact Us About Us

To map gt

Product types Retroviral vectors (also SIN configuration)

RNA (as drug product or ldquostarting materialrdquo

for cell therapy)

Cell banks

Cell therapeutic products

(stem cells T cells DCs Cell lines)

Clean rooms 7 clean rooms class B

4 clean rooms class C

Spare capacity 2017 30 | 2018 70

EUFETS GmbH

Vollmersbachstr 66

55743 Idar-Oberstein

Germany

Simone Gans

infoeufetscom

wwweufetscom

Contact Us About Us

To map gt

Product types Advanced Therapy Medicinal Products (ATMPs)

like gene therapies (eg CAR-T cells)

somatic cell therapies (eg dendritic cells)

tissue engineering products

hematopoietic stem cells

Clean rooms - 10 completely separated clean room

- Total 21 class B manufacturing rooms

Spare capacity 2017 3 clean room suites with two class B

manufacturing rooms each

2018 2 clean room suites with two

class B manufacturing rooms each

Fraunhofer Institute for Cell Therapy

and Immunology IZI

Perlickstrasse 1

D-04103 Leipzig

Germany

Dr Gerno Schmiedeknecht

Gernoschmiedeknechtizifraunhoferde

wwwizifraunhoferde

Contact Us About Us

To map gt

Product types Lentivirus

Associated adenovirus (AAVs)

CD34+ transduced cells

Embryonic stem cells

iPS cells

Clean rooms 4 suites for Drug substance manufacturing

2 suites for FampF

Overall capacity Approx 2000msup2

Spare capacity Enquire contactyposkesicom

YPOSKESI

26 rue Henri Auguste-Desbruegraveres

F-91100 CORBEIL-ESSONNES

France

Alain LAMPROYE

contactyposkesicom

wwwyposkesicom

Contact Us About Us

To map gt

Discussing the future of bioprocessing

with Saint Gobain Akron

Remedi and CRC for Cell Therapy

Manufacturing

Product types Retroviral vectors (ie Lentiviral)

Adeno-associated viral vectors (AAV)

Measles vectors

Adenoviral vectors and Pox virus vectors (MVA)

Ample experience with cell lines like HEK293 VERO CHO

MCDK and customer specific platforms

Clean rooms 5

Overall capacity Approx 250msup2

Spare capacity Enquire infobataviabiosciences

Batavia Biosciences

Zernikedraaf 16

2333 CN Leiden

The Netherlands

V Franssen

infobataviabiosciences

wwwbataviabiosciencescom

Contact Us About Us

To map gt

The Rapporteurrsquos Report explores the role of automation in bioprocessing

Product types Genetically modified and native ATMPs

mesenchymal stem cells (MSC)

hematopoietic stem cells (HSC)

lymphocytes amp monocytes (eg NK DC)

retro- and lentiviral vector transduction

Clean rooms 7 (5 class B 2 class C)

Overall capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 available

2018 available

APCETH

GmbH amp Co KG

Haidgraben 5

85521 Ottobrunn

Germany

Christine Guumlnther CEO

Ulrike Verzetnitsch CTO

contactapcethcom

+49 (0)89 7009608 0

wwwapcethcom

Contact Us About Us

To map gt

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 8: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Retroviral vectors (also SIN configuration)

RNA (as drug product or ldquostarting materialrdquo

for cell therapy)

Cell banks

Cell therapeutic products

(stem cells T cells DCs Cell lines)

Clean rooms 7 clean rooms class B

4 clean rooms class C

Spare capacity 2017 30 | 2018 70

EUFETS GmbH

Vollmersbachstr 66

55743 Idar-Oberstein

Germany

Simone Gans

infoeufetscom

wwweufetscom

Contact Us About Us

To map gt

Product types Advanced Therapy Medicinal Products (ATMPs)

like gene therapies (eg CAR-T cells)

somatic cell therapies (eg dendritic cells)

tissue engineering products

hematopoietic stem cells

Clean rooms - 10 completely separated clean room

- Total 21 class B manufacturing rooms

Spare capacity 2017 3 clean room suites with two class B

manufacturing rooms each

2018 2 clean room suites with two

class B manufacturing rooms each

Fraunhofer Institute for Cell Therapy

and Immunology IZI

Perlickstrasse 1

D-04103 Leipzig

Germany

Dr Gerno Schmiedeknecht

Gernoschmiedeknechtizifraunhoferde

wwwizifraunhoferde

Contact Us About Us

To map gt

Product types Lentivirus

Associated adenovirus (AAVs)

CD34+ transduced cells

Embryonic stem cells

iPS cells

Clean rooms 4 suites for Drug substance manufacturing

2 suites for FampF

Overall capacity Approx 2000msup2

Spare capacity Enquire contactyposkesicom

YPOSKESI

26 rue Henri Auguste-Desbruegraveres

F-91100 CORBEIL-ESSONNES

France

Alain LAMPROYE

contactyposkesicom

wwwyposkesicom

Contact Us About Us

To map gt

Discussing the future of bioprocessing

with Saint Gobain Akron

Remedi and CRC for Cell Therapy

Manufacturing

Product types Retroviral vectors (ie Lentiviral)

Adeno-associated viral vectors (AAV)

Measles vectors

Adenoviral vectors and Pox virus vectors (MVA)

Ample experience with cell lines like HEK293 VERO CHO

MCDK and customer specific platforms

Clean rooms 5

Overall capacity Approx 250msup2

Spare capacity Enquire infobataviabiosciences

Batavia Biosciences

Zernikedraaf 16

2333 CN Leiden

The Netherlands

V Franssen

infobataviabiosciences

wwwbataviabiosciencescom

Contact Us About Us

To map gt

The Rapporteurrsquos Report explores the role of automation in bioprocessing

Product types Genetically modified and native ATMPs

mesenchymal stem cells (MSC)

hematopoietic stem cells (HSC)

lymphocytes amp monocytes (eg NK DC)

retro- and lentiviral vector transduction

Clean rooms 7 (5 class B 2 class C)

Overall capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 available

2018 available

APCETH

GmbH amp Co KG

Haidgraben 5

85521 Ottobrunn

Germany

Christine Guumlnther CEO

Ulrike Verzetnitsch CTO

contactapcethcom

+49 (0)89 7009608 0

wwwapcethcom

Contact Us About Us

To map gt

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 9: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Advanced Therapy Medicinal Products (ATMPs)

like gene therapies (eg CAR-T cells)

somatic cell therapies (eg dendritic cells)

tissue engineering products

hematopoietic stem cells

Clean rooms - 10 completely separated clean room

- Total 21 class B manufacturing rooms

Spare capacity 2017 3 clean room suites with two class B

manufacturing rooms each

2018 2 clean room suites with two

class B manufacturing rooms each

Fraunhofer Institute for Cell Therapy

and Immunology IZI

Perlickstrasse 1

D-04103 Leipzig

Germany

Dr Gerno Schmiedeknecht

Gernoschmiedeknechtizifraunhoferde

wwwizifraunhoferde

Contact Us About Us

To map gt

Product types Lentivirus

Associated adenovirus (AAVs)

CD34+ transduced cells

Embryonic stem cells

iPS cells

Clean rooms 4 suites for Drug substance manufacturing

2 suites for FampF

Overall capacity Approx 2000msup2

Spare capacity Enquire contactyposkesicom

YPOSKESI

26 rue Henri Auguste-Desbruegraveres

F-91100 CORBEIL-ESSONNES

France

Alain LAMPROYE

contactyposkesicom

wwwyposkesicom

Contact Us About Us

To map gt

Discussing the future of bioprocessing

with Saint Gobain Akron

Remedi and CRC for Cell Therapy

Manufacturing

Product types Retroviral vectors (ie Lentiviral)

Adeno-associated viral vectors (AAV)

Measles vectors

Adenoviral vectors and Pox virus vectors (MVA)

Ample experience with cell lines like HEK293 VERO CHO

MCDK and customer specific platforms

Clean rooms 5

Overall capacity Approx 250msup2

Spare capacity Enquire infobataviabiosciences

Batavia Biosciences

Zernikedraaf 16

2333 CN Leiden

The Netherlands

V Franssen

infobataviabiosciences

wwwbataviabiosciencescom

Contact Us About Us

To map gt

The Rapporteurrsquos Report explores the role of automation in bioprocessing

Product types Genetically modified and native ATMPs

mesenchymal stem cells (MSC)

hematopoietic stem cells (HSC)

lymphocytes amp monocytes (eg NK DC)

retro- and lentiviral vector transduction

Clean rooms 7 (5 class B 2 class C)

Overall capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 available

2018 available

APCETH

GmbH amp Co KG

Haidgraben 5

85521 Ottobrunn

Germany

Christine Guumlnther CEO

Ulrike Verzetnitsch CTO

contactapcethcom

+49 (0)89 7009608 0

wwwapcethcom

Contact Us About Us

To map gt

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 10: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Lentivirus

Associated adenovirus (AAVs)

CD34+ transduced cells

Embryonic stem cells

iPS cells

Clean rooms 4 suites for Drug substance manufacturing

2 suites for FampF

Overall capacity Approx 2000msup2

Spare capacity Enquire contactyposkesicom

YPOSKESI

26 rue Henri Auguste-Desbruegraveres

F-91100 CORBEIL-ESSONNES

France

Alain LAMPROYE

contactyposkesicom

wwwyposkesicom

Contact Us About Us

To map gt

Discussing the future of bioprocessing

with Saint Gobain Akron

Remedi and CRC for Cell Therapy

Manufacturing

Product types Retroviral vectors (ie Lentiviral)

Adeno-associated viral vectors (AAV)

Measles vectors

Adenoviral vectors and Pox virus vectors (MVA)

Ample experience with cell lines like HEK293 VERO CHO

MCDK and customer specific platforms

Clean rooms 5

Overall capacity Approx 250msup2

Spare capacity Enquire infobataviabiosciences

Batavia Biosciences

Zernikedraaf 16

2333 CN Leiden

The Netherlands

V Franssen

infobataviabiosciences

wwwbataviabiosciencescom

Contact Us About Us

To map gt

The Rapporteurrsquos Report explores the role of automation in bioprocessing

Product types Genetically modified and native ATMPs

mesenchymal stem cells (MSC)

hematopoietic stem cells (HSC)

lymphocytes amp monocytes (eg NK DC)

retro- and lentiviral vector transduction

Clean rooms 7 (5 class B 2 class C)

Overall capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 available

2018 available

APCETH

GmbH amp Co KG

Haidgraben 5

85521 Ottobrunn

Germany

Christine Guumlnther CEO

Ulrike Verzetnitsch CTO

contactapcethcom

+49 (0)89 7009608 0

wwwapcethcom

Contact Us About Us

To map gt

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 11: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Retroviral vectors (ie Lentiviral)

Adeno-associated viral vectors (AAV)

Measles vectors

Adenoviral vectors and Pox virus vectors (MVA)

Ample experience with cell lines like HEK293 VERO CHO

MCDK and customer specific platforms

Clean rooms 5

Overall capacity Approx 250msup2

Spare capacity Enquire infobataviabiosciences

Batavia Biosciences

Zernikedraaf 16

2333 CN Leiden

The Netherlands

V Franssen

infobataviabiosciences

wwwbataviabiosciencescom

Contact Us About Us

To map gt

The Rapporteurrsquos Report explores the role of automation in bioprocessing

Product types Genetically modified and native ATMPs

mesenchymal stem cells (MSC)

hematopoietic stem cells (HSC)

lymphocytes amp monocytes (eg NK DC)

retro- and lentiviral vector transduction

Clean rooms 7 (5 class B 2 class C)

Overall capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 available

2018 available

APCETH

GmbH amp Co KG

Haidgraben 5

85521 Ottobrunn

Germany

Christine Guumlnther CEO

Ulrike Verzetnitsch CTO

contactapcethcom

+49 (0)89 7009608 0

wwwapcethcom

Contact Us About Us

To map gt

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 12: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Genetically modified and native ATMPs

mesenchymal stem cells (MSC)

hematopoietic stem cells (HSC)

lymphocytes amp monocytes (eg NK DC)

retro- and lentiviral vector transduction

Clean rooms 7 (5 class B 2 class C)

Overall capacity 600msup2 thereof 130msup2 class B

Spare capacity 2017 available

2018 available

APCETH

GmbH amp Co KG

Haidgraben 5

85521 Ottobrunn

Germany

Christine Guumlnther CEO

Ulrike Verzetnitsch CTO

contactapcethcom

+49 (0)89 7009608 0

wwwapcethcom

Contact Us About Us

To map gt

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 13: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Cell and ex vivo gene therapy

immunotherapy and MSCs

Viral vector transduction (retrovirus

lentivirus and adenovirus) isolation

expansion and differentiation of hepatic cells

Clean rooms - GMP area is 600msup2 with 5 clean rooms

- New 600msup2 GMP extension in construction to

be operational in 2017 with 5 new clean rooms

amp 2 incubation rooms

Overall capacity 600msup2 + 600msup2

Spare capacity Enquire myriemmajidmasthercellcom

MASTHERCELL SA

Rue Auguste Piccard

486041 GOSSELIES

BELGIUM

Myriem Majid Marketing Officer

myriemmajidmasthercellcom

0032 71 34 81 19

wwwmasthercellcom

Contact Us About Us

To map gt

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 14: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types All types of cells gene-modified

or not Car-T cells TCR T-cells

Clean rooms 7 fully independent manufacturing lines all in grade B

(switchable to grade C if the process requires) and can

operate both open and closed processes

Overall capacity 3600msup2

Spare capacity Confidential information for customers only

CELLforCURE

3 avenue des Tropiques

ZA de Courtaboeuf 91958

Les Ulis Cedex

France

Pierre-Noeumll LIRSAC

lirsacplfbfr

+ 331 69 82 10 59

wwwcellforcurecom

Contact Us About Us

To map gt

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 15: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Process development

automation

cell and gene therapy manufacturing

Clean rooms 3 class B suites

Overall capacity Approx 100msup2

Spare capacity 2017 66

2018 33

New site with 500msup2 ready by 2019 (20 booked)

Atvio Biotech Ltd

Ohad Karnieli CEO

ohadat-viocom

wwwat-viocom

Contact Us About Us

To map gt

The Bigger Picturethe shape of the advanced therapies market in 2025

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 16: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Vaccines amp biotherapeutics in BSL2

Viruses amp Viral vectors

mAb

Rec proteins

Live attenuated organismsm

Clean rooms 9

Overall capacity Approx 900msup2 (cGMP areas)

Spare capacity 3 Ha of land allowing space for future extension

NOVASEP Management center

39 rue Saint-Jean de Dieu

69007 Lyon

FRANCE

NOVASEP Production site

Rue des Professeurs Jeener et Brachet 12

6041 Gosselies

Belgium

Ceacutedric Delsemme Market Director Biopharma CMO

cedricdelsemmenovasepcom

wwwnovasepcom

Contact Us About Us

To map gt

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 17: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Plasmid DNA API raw material for viral vector

and mRNA production Proteins vaccines enzymes

antibody fragments cytokines etc from

microbial expression systems

Clean rooms 6

Overall capacity Approx 600msup2

Spare capacity Enquire infobiologicseurogenteccom

Eurogentec

Rue Bois Saint-Jean 5

B-4102 Seraing

Belgium

Pascal Bolon

infobiologicseurogenteccom

wwweurogenteccom

Contact Us About Us

To map gt

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt

Page 18: FINVECTOR Manufacturing Capacities in Europe 2017 · 2018-01-14 · Advanced Therapy Medicinal Products (ATMPs), like gene therapies (e.g. CAR-T cells) somatic cell therapies (e.g.

Product types Pivotal trial and early market supply volumes of all ATMPs

Bulk viral vectors and both gene modified and non-gene

modified cells

Multiple simultaneous autologous batch manufacture

or a single 500-1000 litre allogeneic batch

Clean rooms 12 x 100m2 Grade B to C clean rooms

Each module is physically segregated and served by its own

dedicated single pass full fresh air HVAC

Centralised warehousing and both segregated and

centralised QC services that can be tailored to suit

individual requirements

Spare capacity Facility to open mid 2017

Stevenage Bioscience Catalyst

Gunnels Wood Road

Stevenage

Hertfordshire

SG1 2FX

Ute Brassat

infoctcatapultorguk

wwwctcatapultorguk

Contact Us About Us

To map gt